These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9658584)

  • 1. Csk-mediated phosphorylation of substrates is regulated by substrate tyrosine phosphorylation.
    Amrein KE; Molnos J; zur Hausen JD; Flint N; Takacs B; Burn P
    Farmaco; 1998 Apr; 53(4):266-72. PubMed ID: 9658584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of a physical and functional interaction between Csk and Lck which involves the SH2 domain of Csk and is mediated by autophosphorylation of Lck on tyrosine 394.
    Bougeret C; Delaunay T; Romero F; Jullien P; Sabe H; Hanafusa H; Benarous R; Fischer S
    J Biol Chem; 1996 Mar; 271(13):7465-72. PubMed ID: 8631775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism.
    Sondhi D; Xu W; Songyang Z; Eck MJ; Cole PA
    Biochemistry; 1998 Jan; 37(1):165-72. PubMed ID: 9425036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyr394 and Tyr505 are autophosphorylated in recombinant Lck protein-tyrosine kinase expressed in Escherichia coli.
    Jullien P; Bougeret C; Camoin L; Bodeus M; Durand H; Disanto JP; Fischer S; Benarous R
    Eur J Biochem; 1994 Sep; 224(2):589-96. PubMed ID: 7523116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: Fyn is essential for tyrosine phosphorylation of Csk-binding protein/phosphoprotein associated with glycolipid-enriched microdomains in lipid rafts in resting T cells.
    Yasuda K; Nagafuku M; Shima T; Okada M; Yagi T; Yamada T; Minaki Y; Kato A; Tani-Ichi S; Hamaoka T; Kosugi A
    J Immunol; 2002 Sep; 169(6):2813-7. PubMed ID: 12218089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor.
    Vang T; Torgersen KM; Sundvold V; Saxena M; Levy FO; Skålhegg BS; Hansson V; Mustelin T; Taskén K
    J Exp Med; 2001 Feb; 193(4):497-507. PubMed ID: 11181701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of C-terminal SRC kinase from the immune synapse by a new binding protein.
    Rahmouni S; Vang T; Alonso A; Williams S; van Stipdonk M; Soncini C; Moutschen M; Schoenberger SP; Mustelin T
    Mol Cell Biol; 2005 Mar; 25(6):2227-41. PubMed ID: 15743820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants for Csk-catalyzed tyrosine phosphorylation of the Src tail.
    Wang D; Huang XY; Cole PA
    Biochemistry; 2001 Feb; 40(7):2004-10. PubMed ID: 11329267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SH2 domain is required for stable phosphorylation of p56lck at tyrosine 505, the negative regulatory site.
    Gervais FG; Chow LM; Lee JM; Branton PE; Veillette A
    Mol Cell Biol; 1993 Nov; 13(11):7112-21. PubMed ID: 8413300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSK associates with the TCR zeta and epsilon chains via its SH2 domain; a mechanism for turning off TCR signaling.
    Catipović B
    Lijec Vjesn; 1996; 118(11-12):264-71. PubMed ID: 9172452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of a Src kinase at the autophosphorylation site in the absence of Src kinase activity.
    Chiang GG; Sefton BM
    J Biol Chem; 2000 Mar; 275(9):6055-8. PubMed ID: 10692391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophosphorylation of Src and Yes blocks their inactivation by Csk phosphorylation.
    Sun G; Sharma AK; Budde RJ
    Oncogene; 1998 Sep; 17(12):1587-95. PubMed ID: 9794236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking-based substrate recognition by the catalytic domain of a protein tyrosine kinase, C-terminal Src kinase (Csk).
    Lee S; Ayrapetov MK; Kemble DJ; Parang K; Sun G
    J Biol Chem; 2006 Mar; 281(12):8183-9. PubMed ID: 16439366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subdomain X of the kinase domain of Lck binds CD45 and facilitates dephosphorylation.
    Felberg J; Lefebvre DC; Lam M; Wang Y; Ng DH; Birkenhead D; Cross JL; Johnson P
    J Biol Chem; 2004 Jan; 279(5):3455-62. PubMed ID: 14625311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Csk expressed in Escherichia coli is autophosphorylated on tyrosine residue(s).
    Bougeret C; Rothhut B; Jullien P; Fischer S; Benarous R
    Oncogene; 1993 May; 8(5):1241-7. PubMed ID: 7683130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44-initiated cell spreading induces Pyk2 phosphorylation, is mediated by Src family kinases, and is negatively regulated by CD45.
    Li R; Wong N; Jabali MD; Johnson P
    J Biol Chem; 2001 Aug; 276(31):28767-73. PubMed ID: 11369760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of C-terminal Src kinase by siRNA-mediated RNA interference augments T cell receptor signaling in mature T cells.
    Vang T; Abrahamsen H; Myklebust S; Enserink J; Prydz H; Mustelin T; Amarzguioui M; Tasken K
    Eur J Immunol; 2004 Aug; 34(8):2191-9. PubMed ID: 15259016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase.
    Lee S; Lin X; Nam NH; Parang K; Sun G
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14707-12. PubMed ID: 14657361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of halogenation on tyrosine phosphorylation and peptide binding to the SRC homology 2 domain of lymphocyte-specific protein tyrosine kinase.
    Okamura T; Kikuchi T; Nodaira M; Odaka K; Fukushi K; Irie T
    Biol Pharm Bull; 2012; 35(3):433-7. PubMed ID: 22382333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.